Hyperion Asset Management becomes substantial shareholder in Fisher & Paykel Healthcare

Hyperion Asset Management Limited disclosed on October 20, 2025, that it became a substantial shareholder in Fisher & Paykel Healthcare Corp. Ltd on October 16, 2025. The firm now holds 30,432,527 ordinary shares, representing 5.182% of the total 587,262,856 shares in the class. As an investment manager, Hyperion Asset Management controls the voting and/or disposal of these securities.

The disclosure detailed numerous transactions between June 23, 2025, and October 16, 2025. Key purchases included NZD42,674,072.14 for 1,180,292 shares on October 16, 2025, and NZD24,733,936.70 for 661,606 shares on July 2, 2025. Significant acquisitions were also made on July 14, 2025, for NZD28,383,932.08 (796,552 shares), and August 8, 2025, for NZD11,433,326.21 (307,721 shares).

The registered holders of these securities include BNP Paribas Australia Ltd and Citicorp Nominees Pty Ltd. The disclosure also noted an in-specie transfer out on July 14, 2025, amounting to -NZD20,252,886.85 for 568,932 shares.